New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Friday 20 November 2026
Export CVS’s income statement to Excel — free account
CVS Health Corporation
CVSCVS Health Corporation’s revenue for fiscal 2025 (year ended December 2025) was $402.1 billion, up 7.85% from fiscal 2024.
- Revenue
- +5.37%
- EPS
- n/m
- Free cash flow
- +3,886.7%
- Total debt
- −7.83%
Quarter to September 2026, against a year earlier
80.05
1.30
−1.60%
After hours trading: 80.05, unchanged, last trade Thu 7:55pm Eastern.
Follow CVS
Alert me
Revenue to profit Q3 FY2026, quarter to 30 September 2026
Of every $100 of revenue, $2.00 was left as profit. Gross margin has fallen two quarters running, from 44.8% to 43.6%. What is an income statement?
| Revenue | 108.4 | 100.0% |
|---|---|---|
| Cost of revenue | −61.2 | −56.4% |
| Gross profit | 47.2 | 43.6% |
| Other operating costs | −43.6 | −40.3% |
| Operating income | 3.6 | 3.3% |
| Other income, net | −0.7 | −0.7% |
| Income tax | −0.7 | −0.6% |
| Net income | 2.2 | 2.0% |
Net margin (right axis)
| Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | |
|---|---|---|---|---|
| Revenue | $105.7B | $100.4B | $106.1B | $108.4B |
| Operating income | $2.1B | $4.7B | $4.7B | $3.6B |
| Net income | $2.9B | $3.0B | $3.0B | $2.2B |
| Net margin (right axis) | 2.8% | 2.9% | 2.8% | 2.0% |
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
Revenue |
108,399.00 | 106,096.00 | 100,426.00 | 105,693.00 |
+8 more quarters Free account |
Revenue Growth |
5.37% | 7.26% | 6.17% | 8.17% | |
Cost of Revenue |
61,185.00 | 58,862.00 | 55,444.00 | 59,060.00 | |
Gross Profit |
47,214.00 | 47,234.00 | 44,982.00 | 46,633.00 | |
Operating Income |
3,566.00 | 4,703.00 | 4,680.00 | 2,112.00 | |
Non-operating Interest Expenses |
747.00 | 757.00 | 774.00 | 787.00 | |
Non-operating Income/Expense |
(717.00) | (726.00) | (742.00) | (758.00) | |
| 2,849.00 | 3,977.00 | 3,938.00 | 1,354.00 | ||
Income Tax Provision |
678.00 | 982.00 | 981.00 | (1,569.00) | |
Income after Tax |
2,171.00 | 2,995.00 | 2,957.00 | 2,923.00 | |
Non-Controlling Interest |
(1.00) | 16.00 | 14.00 | (20.00) | |
Net Income Common |
2,172.00 | 2,979.00 | 2,943.00 | 2,943.00 | |
EPS (Basic) |
1.70 | 2.33 | 2.31 | 2.32 | |
EPS (Diluted) |
1.68 | 2.31 | 2.30 | 2.30 | |
Shares (Basic, Weighted) |
1,282.00 | 1,279.00 | 1,273.00 | 1,267.00 | |
Shares (Diluted, Weighted) |
1,291.00 | 1,287.00 | 1,279.00 | 1,271.00 | |
Gross Margin |
43.56% | 44.52% | 44.79% | 44.12% | |
EBIT Margin |
3.29% | 4.43% | 4.66% | 2.00% | |
EBT margin |
2.63% | 3.75% | 3.92% | 1.28% | |
Net Profit Margin |
2.00% | 2.81% | 2.93% | 2.78% | |
EBITDA |
4,698.00 | 5,829.00 | 5,795.00 | 3,259.00 | |
EBIT |
3,566.00 | 4,703.00 | 4,680.00 | 2,112.00 | |
Income from Continuous Operations |
2,171.00 | 2,995.00 | 2,957.00 | 2,923.00 | |
Consolidated Net Income/Loss |
2,171.00 | 2,995.00 | 2,957.00 | 2,923.00 | |
EPS (Basic, from Continuous Ops) |
1.69 | 2.34 | 2.32 | 2.29 | |
EPS (Diluted, from Cont. Ops) |
1.68 | 2.33 | 2.31 | 2.30 | |
EPS (Basic, Consolidated) |
1.69 | 2.34 | 2.32 | 2.29 | |
EPS (Diluted, Consolidated) |
1.68 | 2.33 | 2.31 | 2.30 | |
Shares (Diluted, Average) |
1,291.00 | 1,287.00 | 1,279.00 | 1,277.00 | |
EBITDA Margin |
4.33% | 5.49% | 5.77% | 3.08% | |
Operating Cash Flow Margin |
4.36% | 5.98% | 4.23% | 3.21% |
In millions of $ except per-share values · columns are period end dates · fundamentals updated 18 Nov 2026